News | January 18, 2021
Zydus eyes $6 bn market with strong COVID-19 portfolio
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
This vaccination programme is based on the principles of priority groups to be vaccinated and health care workers both in the government and private sectors including ICDS workers will receive the vaccine during this phase.
The company is expecting tremendous growth and a better quarterly performance
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Strides Pharma Science Limited is pleased to announce that Aditya Puri joins the Strides Group as an Advisor and also will be a Director of its associate Company, Stelis Biopharma.
Subscribe To Our Newsletter & Stay Updated
